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Objectives: There are conflicting data on cancer incidence and mortality in psychiatric
patients, although most studies suggest that while cancer mortality is higher, incidence is
no different from that in the general population. Different methodologies and outcomes
may account for some of the conflicting results. We investigated the association between
mental illness and cancer incidence, first admission rates, and mortality in Nova Scotia
using a standard methodology.
Method: A population-based record-linkage study of 247 344 patients in contact with
primary care or specialist mental health services during 1995 to 2001 was used. Records
were linked with cancer registrations and death records.
Results: Cancer mortality was 72% higher in males (95%CI, 63% to 82%) and 59% higher
in females (95%CI, 49% to 69%) among patients in contact with mental health services.
This was reflected in similarly elevated first admission rates. However, there was weaker
and less consistent evidence for increased incidence. For several cancer sites, incidence
rate ratios were lower than might be expected given the mortality and first admission rate
ratios, and no higher than that of the general population. These were melanoma, prostate,
bladder, and colorectal cancers in males.
Conclusion: People with mental illness in Nova Scotia have increased mortality from
cancer, which cannot always be explained by increased incidence. Possible explanations
for further study include delays in detection or initial presentation leading to more
advanced staging at diagnosis, and difficulties in communication or access to health care.
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Clinical Implications
 People with mental illness, including people seen only in primary care, have a higher mortality
from cancer. This cannot always be explained by increased incidence, especially in males.
 If lifestyle were the only explanation, incidence would consistently reflect the increased
mortality rate. Other reasons might include delays in detection or initial presentation, as
suggested by more advanced staging at presentation, and difficulties in communication or
accessing health care.
 Efforts should be considered to address any inequities in the delivery of services, including
screening and diagnosis or treatment for people with psychiatric illness, including those seen
in primary care.
Limitations
 We relied on routine administrative data that may be subject to recording bias.
 There may have been additional influences on mortality such as marital status, length of time
since first contact with services, educational status, and cancer staging that we could not
control for in the analysis.
 As this was an epidemiologic study using administrative claims data, detailed clinical
information, or information on risk factors such as smoking, was not available.
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Studies of cancer incidence and mortality in psychiatricpatients have had mixed results. Some authors have
reported lower than expected cancer incidence or mortality in
psychiatric patients, while others have found no
association.1–3 Still others have found an increased risk of
incidence or mortality.4,5 Some of these discrepancies may be
explained by differences between psychiatric diagnoses.
Schizophrenia has particularly been associated with a reduced
incidence of cancer.6–11 In terms of specific sites, the risk of
cancers of the lung, prostate, cervix, and uterus appear to be
lower in patients with schizophrenia despite risk factors such
as increased smoking,12,13 while the risk for colon cancer is
increased.13 One of these studies also found that cancer rates
for bipolar affective disorder were no different from those of
the general population.13 Explanations have included a
tumour suppressor gene or enhanced natural killer cell activ-
ity.14 Antipsychotics and lithium may also have protective
effects.15,16 On the other hand, antipsychotic medications have
also been associated with an increased risk of colon cancer in
patients with schizophrenia.13
The use of different methodologies and cancer outcomes may
also account for some of the conflicting results. Some studies
are restricted to patients in hospital.13 In addition, cancer mor-
tality may not be an ideal marker of the risk of cancer as it is
affected by both susceptibility to developing the disorder, and
subsequent survival rates.17 Only one population-based study
has evaluated both at the same time and showed that while
people with mental illness in Western Australia did not show
an increased incidence rate of cancer, they did have higher
cancer mortality.17 This suggests a higher cancer case fatality
rate among people with mental illness. However, the sample
was restricted to those in contact with specialist psychiatric
services and did not include people treated in primary care,
where most people are treated. All-cause mortality is higher
for these patients too, and although the relative risk is lower
than for patients seen in specialist services, patients with
mental illness seen in primary care account for 72% of deaths
from all causes in absolute terms.18
Another finding from Australia was that hospitalization rate
ratios for many physical comorbidities are lower than corre-
sponding mortality rate ratios, suggesting that people with
mental illness may not receive the level of health care com-
mensurate with their illness.19
Studies from Australia, where both private health insurance
and hospitals play a sizable role in providing medically nec-
essary care, may not apply to jurisdictions such as Canada
with universal health care provision. We therefore compared
cancer incidence, first admission, and mortality rates for peo-
ple with psychiatric disorder with the general population of
Nova Scotia. We specifically investigated whether any
increase in mortality for psychiatric patients was reflected in
the other 2 measures.
Method
Data Sources
We evaluated the association between cancer mortality and
psychiatric disorder for all patients of specialist services and
primary care across Nova Scotia.
We used the following provincial administrative databases,
held at the PHRU of Dalhousie University, to identify anyone
in contact with health services for psychiatric problems20:
 The Medical Services Insurance database contains all
fee-for-service claims by physicians including patient
demographics, date of service, and diagnosis from the
ICD-9-CM. This includes family physicians and
psychiatrists.
 The CIHI-DAD includes admissions, separation dates,
diagnoses, and procedures.
 MHOIS data contains service contacts, demographics,
and diagnoses in the public sector. This includes contacts
with all mental health clinicians, not just physicians.
This method is consistent with the definition used by PHAC
for the surveillance of treated psychiatric disorders.21,22 We
included patients whose first psychiatric contact with pri-
mary or specialist services occurred between January 1,
1995, and December 31, 2001, and linked data using the pro-
vincial health card number as a unique identifier. Health card
numbers are present in over 99% of records, irrespective of
database, and encrypted to ensure confidentiality. We will
describe these people as psychiatric patients for the rest of the
paper. The Capital Health Research Ethics Board approved
the protocol.
Administrative data have several advantages over commu-
nity surveys or data derived from individual clinical settings.
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Abbreviations used in this article
CIHI-DAD Canadian Institute for Health Information—
Discharge Abstract Database
DSM-IV Diagnostic and Statistical Manual of Mental
Disorders—Fourth Edition
ICD-9 International Classification of Diseases—
Ninth Revision
ICD-9-CM International Classification of Diseases—
Ninth Revision—Clinical Modification
MHOIS Mental Health Outpatient Information System
NSCR Nova Scotia Cancer Registry
PHAC Public Health Agency of Canada
PHRU Population Health Research Unit
They provide accessible longitudinal data for an entire juris-
diction at relatively little cost, and both Health Canada and
PHAC have used administrative datasets for chronic disease
surveillance.21–23 Nevertheless, because these data were
designed for billing purposes, rather than disease surveil-
lance, studies have measured accuracy over jurisdictions,
over time, and against other measures.
In reabstraction studies, the CIHI-DAD has an accuracy rate
of 97% to 99% for demographic data, including sex, treating
physician, admission and discharge dates, and discharge des-
tination.24,25 In the case of the MHOIS, psychiatric diagnoses
recorded on MHOIS showed significant agreement with the
relevant items in standardized clinical ratings completed by
treating clinicians (the Health of the Nation Outcome
Scales).26
Support for the validity of the Medical Services Insurance
database comes from agreement across jurisdictions for the
prevalence of morbidity using billings data from physicians.
The prevalence of psychiatric disorders meeting PHAC’s case
definition, about 15%, was similar across Nova Scotia, British
Columbia, Alberta, and Ontario.21,22 The rate also remained
stable over a 5-year period. Hospital admissions for these dis-
orders, as captured by the CIHI-DAD, accounted for 0.5% of
these patients; the remaining 99.5% were determined from
billings by provincial physicians. This degree of stability
across jurisdictions matches the findings of the National Dia-
betes Surveillance System, the prototype for chronic disease
surveillance in Canada.23
Finally, although the administrative databases use ICD-9-CM
diagnoses, mental health clinicians make their diagnoses
using the DSM-IV.27 Clinicians in publicly funded facilities
attend DSM-IV training courses to improve diagnostic accu-
racy. All DSM-IV diagnoses have equivalent ICD-9-CM
codes.
We then transferred this data file to Cancer Care Nova Scotia
who linked it to the NSCR to identify cancer incidence rates
for the cohort. The NSCR has population-based incidence
data that date from 1964.28 All malignant and in-situ tumours
are reportable by law within the province. Other sources of
data include pathology reports (1982 onwards) and death cer-
tificate information for all provincial deaths (from 1989
onwards). Registry operations meet the consensus on cancer
registration standards outlined by both the Canadian Cancer
Registry and the North American Association of Central Can-
cer Registries. The NSCR works collaboratively with Statis-
tics Canada to ensure that Nova Scotia data are part of the
national Canadian Cancer Registry. We classified cancers
according to the ICD-9 classification of diseases at the 3-digit
level. This classification followed the same system used for
classifying cancers by the NSCR. The cancer sites selected for
analysis were the most frequent cancers in males and
females.
Classification of Mental Disorders
The PHAC case-definition includes ICD-9 diagnoses from
290 to 319, inclusive. We also included nonspecific mental
disorders outside Chapter 5 of ICD-9, such as injury of unde-
termined intention or psychosocial factors influencing health
status, to ensure comparability with previous Australian
work.17 We did not include non-Chapter 5 diagnoses of pri-
mary care patients, as they would not necessarily be
psychiatric.
We included contacts with primary or specialist services. We
used a hierarchy of inpatient, compared with outpatient, and
specialist, compared with primary care, reflecting both the
increasing percentage of patients with severe mental illness
and data reliability. It also allowed comparison with
Australian data.17 We grouped disorders into dementia and
other organic conditions (290 to 294), schizophrenia (295),
other nonaffective psychoses (297, 298.0, and 298.1), alco-
hol and (or) drug disorders (303 to 305), mood disorders
(affective psychoses and [or] depression to 296, 298.2 to
298.9, 300.4, and 311), neuroses (300 except 300.4), person-
ality disorders (301), adjustment reactions (308 to 309), and
other mental disorders (all remaining Chapter 5 diagnoses
and those outside Chapter 5).
Calculation of Rates and Ratios
Rates were calculated using the inception cohort method.19
The start of follow-up was the date of each patient’s first con-
tact with a clinician. Patients were censored at the time of
occurrence of the event under study, death, or December 31,
2001. The cohort was limited to people whose first contact
with a clinician occurred in the study period, excluding peo-
ple whose first contact occurred prior to the start of
follow-up. This avoids the possibility of survivorship bias,
which could otherwise occur if cancer risk changes with time
since first contact with a clinician.19 We derived mortality
rates from the Statistics Canada Vital Statistics Database.
Person-years at risk were calculated separately for each out-
come. We calculated age- and sex-adjusted mortality, first
admission, and incidence rates for carcinoma using the aver-
age population distributions in Nova Scotia from 1995 to
2001 inclusive as the standard weights. We then calculated
rate ratios relative to the rate in the general Nova Scotia popu-
lation using 95%CIs to test for significance. Variance of the
standardized rate ratios was calculated using expansion in
Taylor series, using a logarithmic transformation of the
ratio.29
We assessed whether the rate ratios for mortality, first admis-
sion, and incidence in psychiatric patients were significantly
different from the general population of Nova Scotia as
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indicated by 95%CIs that included a value of 1.0. We also
assessed whether there were differences between mortality,
first admission, and incidence rate ratios.
Regression Analysis
We used Cox regression to compare the risk of each outcome
in the PHRU data from time of first contact for psychiatric dis-
order until the end of follow-up. We included principal psy-
chiatric diagnosis, age (in 10-year increments), sex,
socioeconomic status, and treatment setting and residence
(metropolitan Halifax or elsewhere in the province). We
derived income levels using the average household income
from the 1996 Census for psychiatric patients’ postal codes at
the time of initial contact, and divided them into quarters.
We assessed medical comorbidity leading to admission, as
recorded in the CIHI-DAD, over the year prior to study entry
using the modified Charlson-Deyo Index. This contains 19
categories of comorbidity, primarily defined using ICD-9
codes. Each category has an associated weight, based on the
adjusted risk of 1-year mortality. The overall score reflects the
cumulative increased likelihood of 1-year mortality: the
higher the score, the greater the risk.30
As the analysis was carried out within the administrative data-
bases held at PHRU, we were only able to study the outcomes
(death or first admission) captured by the data. We were not
able to investigate predictors of cancer incidence recorded in
the NSRC because of the nature of the data sharing agreement.
Results
Incidence, First Admission, and Mortality Rates
There were 247 344 people in contact with mental health ser-
vices in the study cohort. This represents just over 25% of
Nova Scotia’s total population of 936 130 in 2005.31 After
their first contact with mental health services, 4690 people
had cancers diagnosed. Tables 1 and 2 show the distribution
of incident cancers by cancer site and sex. The most common
cancer sites were trachea, bronchus, and lung (n = 877),
colorectal (n = 634), prostate (n = 550), and breast (n = 492).
Between 1995 and 2001, 2486 psychiatric patients in the
study cohort died from cancer.
The cancer incidence rate in psychiatric patients was 730 per
100 000 person-years in males (95%CI, 702 to 758 per
100 000 person-years) and 577 per 100 000 person-years in
females (95%CI, 552 to 603 per 100 000 person-years). This
was significantly higher than rates in the general Nova Scotia
population of 603 per 100 000 person-years in males
(95%CI, 594 to 611 per 100 000 person-years) and 442 per
100 000 person-years in females (95%CI, 435 to 448 per
100 000 person-years) as shown by the corresponding rate
ratios (Tables 1 and 2). The incidence rate ratio varied from
1.88 for brain cancer in males (95%CI, 1.65 to 2.15) to 0.91
for melanoma in females (95%CI, 0.73 to 1.07). There were
several cancer sites where incidence was no higher than for
the general population. These were colorectal and prostate
cancer for males, ovarian cancer for females, and bladder
cancer and skin melanoma for both sexes (Tables 1 and 2).
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Table 1 Comparing incidence, first admission, and mortality rates in males
Cancer incidence First admission rate Mortality rate
Cancer Rate ratio 95%CI Rate ratio 95%CI Rate ratio 95%CI
Prostate 1.01 0.95 to 1.07 1.22 1.12 to 1.32 1.39 1.17 to 1.65
Trachea, bronchus, lung 1.45 1.37 to 1.52 1.78 1.63 to 1.94 1.88 1.71 to 2.06
Colorectal 1.05 0.99 to 1.13 1.54 1.38 to 1.72 1.62 1.35 to 1.94
Melanoma 1.05 0.92 to 1.21 1.16 0.89 to 1.51 2.18 1.34 to 3.44
Brain 1.88 1.65 to 2.15 2.44 1.92 to 3.10 2.64 1.92 to 3.62
Bladder 1.03 0.89 to 1.13 1.41 1.23 to 1.61 1.99 1.48 to 2.67
Non-Hodgkin lymphoma 1.52 1.36 to 1.67 1.98 1.68 to 2.33 1.69 1.28 to 2.22
Leukemia 1.35 1.17 to 1.49 1.81 1.48 to 2.21 1.73 1.26 to 2.37
Stomach 1.30 1.14 to 1.51 1.43 1.10 to 1.85 1.62 1.18 to 2.23
Pancreas 1.24 0.94 to 1.41 1.34 1.03 to 1.75 1.53 1.17 to 1.99
Unknown primary 1.69 1.48 to 1.82 1.98 1.64 to 2.39 2.02 1.63 to 2.49
Total 1.21 1.18 to 1.24 1.52 1.47 to 1.58 1.72 1.63 to 1.82
First Admission and Mortality Rates
First admission and mortality rate ratios were higher than inci-
dence in psychiatric patients for both males (Table 1) and
females (Table 2). In terms of specific cancer sites, we
observed the highest cancer mortality and admission rate
ratios for brain cancers in men. In women, the highest mortal-
ity rate ratio was for cancer of the uterus, while the highest
admission rate ratio was for brain cancer followed by cervical
cancer. Cancers of unknown primary site showed high admis-
sion and mortality rates in both sexes.
Comparing Incidence and Mortality Rates
for Specific Cancer Sites
There were important differences between incidence and
mortality rate ratios for several cancer sites. In some cases,
such as cancers of the brain, stomach, trachea, bronchus, and
lung, incidence and mortality rate ratios were similarly raised,
compared with the general population. In a second group,
such as bladder cancer in females, both incidence and mortal-
ity were no higher than that of the general population.
However, in a third group, mortality was higher than might be
expected from the incidence. In this group, mortality was
higher than that of the general population, but incidence was
not. These were melanoma, prostate, bladder, and colorectal
cancers in males (Table 1).
Predictors of First Admission and Mortality
We used Cox regression to analyze risk factors for first admis-
sion and mortality while adjusting for confounders such as
age and sex (Table 3). The risk of first admission for cancer
was 57% higher in psychiatric patients. Admission risk was
also significantly associated with male sex, increasing age,
lower socioeconomic status, metropolitan as opposed to rural
residence, the presence of clinically important comorbidity,
and psychiatric disorder (Table 3). The same variables were
also significantly associated with increases in mortality rates,
with the exception of metropolitan residence (Table 3).
Patients from rural, as opposed to metropolitan, areas had
significantly increased mortality, which was the reverse of
our findings for first admissions.
Sensitivity Analyses by Psychiatric Diagnosis
and Treatment Setting
We reran our models to investigate any differences in first
admission or mortality rate ratios by psychiatric diagnosis
and treatment setting. We were unable to separately analyze
mortality in patients with personality disorders in the absence
of Axis I comorbidity because of insufficient numbers.
Patients with dementia had significantly lower rate ratios for
first admission (0.87; 95%CI, 0.77 to 0.98) and cancer mor-
tality (0.69; 95%CI, 0.56 to 0.85). Patients with schizophre-
nia did not show significantly higher rate ratios for first
admission (1.48; 95%CI, 0.96 to 2.30) and mortality (1.49;
95%CI, 0.71 to 3.14). All other Axis I diagnoses were associ-
ated with higher rate ratios for admission and (or) mortality.
While higher than the general population, there was little dif-
ference in first admission rate ratios between those who had
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Table 2 Comparing incidence, first admission, and mortality rates in females
Cancer incidence First admission rate Mortality rate
Cancer Rate ratio 95%CI Rate ratio 95%CI Rate ratio 95%CI
Breast 1.11 1.05 to 1.18 1.26 1.16 to 1.38 1.52 1.30 to 1.78
Trachea, bronchus, lung 1.49 1.38 to 1.59 1.46 1.30 to 1.65 1.62 1.42 to 1.86
Colorectal 1.45 1.34 to 1.56 1.47 1.31 to 1.66 1.78 1.48 to 2.15
Melanoma 0.91 0.73 to 1.07 1.11 0.84 to 1.47 1.37 0.64 to 2.92
Brain 1.56 1.25 to 1.94 2.15 1.58 to 2.93 1.66 1.08 to 2.54
Bladder 1.04 0.81 to 1.33 1.31 1.03 to 1.66 1.15 0.59 to 2.24
Cervix 1.33 1.12 to 1.57 1.97 1.55 to 2.52 1.73 1.09 to 2.75
Uterus 1.25 1.04 to 1.39 1.37 1.09 to 1.72 3.09 1.98 to 4.83
Ovary 1.15 0.99 to 1.35 1.55 1.24 to 1.93 1.39 1.02 to 1.89
Non-Hodgkin lymphoma 1.30 1.06 to 1.45 1.20 0.96 to 1.51 0.87 0.57 to 1.32
Leukemia 1.29 1.07 to 1.55 1.26 0.96 to 1.65 1.28 0.85 to 1.93
Stomach 1.54 1.23 to 1.92 1.46 1.04 to 2.05 1.86 1.28 to 2.70
Pancreas 1.41 1.12 to 1.65 1.36 1.03 to 1.79 1.50 1.14 to 1.97
Unknown primary 2.04 1.72 to 2.25 1.81 1.51 to 2.18 1.88 1.51 to 2.36
Total 1.31 1.27 to 1.34 1.39 1.34 to 1.45 1.59 1.49 to 1.69
seen a psychiatric specialist (1.81; 95%CI, 1.40 to 2.33), and
those who had only seen a general practitioner (1.61; 95%CI,
1.54 to 1.66). Mortality rate ratios showed a similar pattern for
those seen in psychiatric settings (2.03; 95%CI, 1.35 to 3.05)
and those seen in primary care (1.29; 95%CI, 1.21 to 1.38).
Discussion
Strengths and Limitations
There is literature on the adverse affects of depression on sur-
vival from cancer, especially breast cancer.32–34 There is also
literature on the incidence of carcinoma in schizophrenia, and
whether this is lower than that of the general popula-
tion.35,36 Lastly, there is limited literature comparing inci-
dence and mortality in patients of specialist psychiatric ser-
vices.17 To our knowledge, this is the first study to investigate
cancer incidence, first admission, and mortality rates in peo-
ple with psychiatric disorder that includes primary care,
where most patients receive treatment. Our findings therefore
give a fuller picture of the relation between psychiatric
disorder and cancer.
We found that overall age-standardized cancer mortality was
70% higher in male and 59% higher in female psychiatric
patients than the general population. After adjusting for other
demographic factors and comorbidity, there was a 29% excess
mortality in psychiatric patients. First admissions showed a
similar pattern. One in 5 Canadians have a psychiatric illness
within their lifetime; therefore, any increase in mortality and
hospital admissions in this population is of great public
health concern.
There was weaker and less consistent evidence for increased
incidence. For some cancers, incidence rate ratios were lower
than what might be expected from the corresponding mortal-
ity and first admission rates, and no higher than that of the
general population. These sites were melanoma, colorectal,
bladder, and prostate cancer in males. These findings suggest
that increases in mortality for cancer cannot be solely
explained by greater incidence, and that there is a greater case
fatality rate for some cancers in psychiatric patients.
There are several limitations. We used routinely collected
administrative data that may be subject to recording bias,
especially for diagnosis. Most data concerning the validity of
our case definition of treated psychiatric disorder are for
overall morbidity rather than specific diagnoses. We have
therefore emphasized overall psychiatric morbidity, not sub-
categories, to minimize possible bias. We were unable to
study the effects of lifestyle factors such as alcohol or
tobacco use. Smoking status, in particular, is a potential con-
founder of outcome in many forms of cancer. However, this
would not explain our finding of an increased risk of mortal-
ity and first admission for several cancer sites in the presence
of an incidence that was no higher than that of the general
population. We were unable to separately study the relation
between psychiatric disorder and every type of cancer (for
example, Hodgkin disease) because of small numbers.
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Table 3 Risk factors for mortality and first admissions (adjusted)
First admission Mortality
Variable Adjusted rate ratios 95% CI Adjusted rate ratios 95%CI
Sex, male 1.60 1.59 to 1.61 1.79 1.77 to 1.81
Age (change/decadea) 1.26 1.23 to 1.28 1.37 1.32 to 1.42
Income quarter
$49 562 1.00 n/a 1.00 n/a
$40 184 to $49 561 1.04 1.01 to 1.07 1.06 1.0 to 1.12
$33 776 to $40 183 1.04 1.01 to 1.07 1.07 1.01 to 1.13
$0 to $33 775 1.10 1.07 to 1.17 1.08 1.02 to 1.14
Residence
Rural 1.00 n/a 1.00 n/a
Metropolitan 1.05 1.03 to 1.08 0.95 0.91 to 0.99
Medical comorbidity 7.90 7.72 to 8.08 7.92 7.61 to 8.24
Psychiatric disorder 1.57 1.52 to 1.62 1.29 1.21 to 1.36
aAdded risk per decade of first admission or mortality
n/a = not applicable
However, we included all cancers in calculations of overall
incidence, first admission, and mortality rate ratios.
Administrative data do not contain indicators of disease
severity or disability. We also could not consider the effect of
marital status, length of time since first contact with services,
educational level, or psychiatric legal status. However, stud-
ies from Australia and the United States showed no difference
in all-cause mortality rates between involuntary and voluntary
patients.17,37 Unlike cancer registries in several other coun-
tries, Canadian registries do not have information on cancer
staging. Our results on the effect of variables such as income
or rurality apply to this particular cohort in contact with psy-
chiatric services, and may not generalize to other populations.
Finally, although we were able to adjust for age and sex
through standardization of mortality, first admission, and
incidence rate ratios for males and females, we were only able
to adjust for other confounders such as socioeconomic status
and comorbid illness for mortality and first admission, not for
incidence. Our findings require further study. The definitive
way of comparing incidence, first admission, and mortality
rates would be a prospective cohort study with adjustment for
some of the previously mentioned confounders.
Comparison With Previous Studies
This study and work from Australia, which used a similar
methodology, allow a comparison between health systems
with and without universal health coverage.17 Both studies
found strong and consistent elevations in the mortality rate
ratios but weak and inconsistent evidence for elevated inci-
dence rate ratios. The incidence for several important cancer
sites in psychiatric patients is actually no higher than that of
the general population, notably in males.
The high mortality rate for brain cancers, especially for men,
is also consistent with the Australian study.17 These authors
were able to review the case notes of some of the cohort and
found that most were older patients whose first contact with
psychiatric services occurred only months prior to death. Our
results confirm the need to exclude such diagnoses in older
men presenting for the first time with psychiatric disorder.
Unlike previous work that compared first admission and mor-
tality rates for a range of physical comorbidities,19 the rate
ratios for first admissions were not lower that those for mortal-
ity after adjusting for sociodemographic and other potential
confounders. Our data do not therefore support the suggestion
that people with mental illness are not receiving the level of
acute health care commensurate with their illness, at least in
the particular example of first admission for cancer.
Possible Explanations
There is a common assumption that lifestyle factors, such as
alcohol or tobacco use, explain the increased mortality from
cancer for patients with psychiatric disorder.17,18 If that were
the sole explanation, incidence would consistently reflect the
increased mortality rate. Our study and work from Australia
suggest psychiatric patients are no more likely to develop
some cancers than the general population but still have
increased mortality for the same condition. There may be
several explanations for this increased case fatality rate. One
might be that psychiatric patients are presenting later, and
with more advanced disease, than the general population.17 In
Canada, information on staging is not included in the cancer
registry; therefore, this information could only be collected
clinically or by case note review. However, cancer registries
elsewhere do contain such data.
Another possibility is reduced access to general medical care.
Although first admission rates reflected the increased mortal-
ity risk for psychiatric patients, access may be harder for
interventions that are more elective. This inequity would be
of concern, and would confirm work from Ontario showing
that other marginalized populations, such as those of low
income, are less likely to receive specialist procedures such
as adjuvant or palliative radiotherapy.38,39
Decreased uptake of screening could also explain the
increased mortality for breast cancer in females, or colorectal
and prostate cancer in males. As a result, psychiatric patients
may therefore only present when symptoms or signs become
more obvious in later stages of the disease. Clearly, ability to
pay is not the sole determinant. Is this owing to problems in
registering with a family physician, missed appointments, or
difficulties in communication or scheduling appointments?
Finally, psychiatric patients may have a worse prognosis
even after adjusting for staging at presentation. Survival from
cancer is associated with levels of depression,32–34 emotional
expression, and support.40 This has mostly been studied in
relation to breast cancer33,40 but has also been found in lung,
colon, head and neck, prostate, uterine, ovarian, and colon
and rectal cancers.32,34 Some work suggests that people with
depression prior to the diagnosis of the cancer have a worse
survival rate than those with depression following
diagnosis.32 This would be the situation that would apply to
our cohort of patients.
Conclusions
People with mental illness in Nova Scotia have increased
mortality from cancer, which cannot always be explained by
increased incidence. Further study is needed to identify pos-
sible reasons for this. It is also unclear why the relation
between psychiatric morbidity and cancer varies by both sex
and site. For instance, the greatest disparity between inci-
dence and mortality occurs in males.
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Résumé : La mortalité par cancer excessive chez les patients psychiatriques
Objectifs : Il y a des données contradictoires sur l’incidence du cancer et la mortalité chez les
patients psychiatriques, bien que la plupart des études suggèrent que même si la mortalité par cancer
est plus élevée, l’incidence n’en est pas différente de celle de la population générale. Différentes
conclusions et méthodologies peuvent expliquer certains des résultats contradictoires. Nous avons
recherché l’association entre la maladie mentale et l’incidence du cancer, les taux de première
hospitalisation, et la mortalité en Nouvelle-Écosse à l’aide d’une méthodologie standard.
Méthode : Une étude de couplage de dossiers dans la population de 247 344 patients en contact
avec des soins primaires ou des services d’un spécialiste en santé mentale de 1995 à 2001 a été
utilisée. Les dossiers étaient couplés avec les registres de cancer et les enregistrements de décès.
Résultats : La mortalité par cancer était 72 % plus élevée chez les hommes (95 % IC, 63 % à 82 %)
et 59 % plus élevée chez les femmes (95 % IC, 49 % à 69 %), parmi les patients en contact avec des
services de santé mentale. Cela se reflétait dans les taux de première hospitalisation semblablement
élevés. Toutefois, les données probantes d’une incidence accrue étaient plus faibles et moins
cohérentes. À plusieurs sièges du cancer, les ratios des taux d’incidence étaient plus faibles que ce
qui pouvait être escompté, étant donné les ratios des taux de mortalité et de première hospitalisation,
et ils n’étaient pas plus élevés que ceux de la population générale. Il s’agissait de mélanomes, de
cancer de la prostate, de la vessie et du cancer colorectal chez des hommes.
Conclusion : En Nouvelle-Écosse, les gens souffrant de maladie mentale ont une mortalité accrue
par cancer, qui ne s’explique pas toujours par une incidence accrue. Des explications possibles pour
de futures études sont entre autres les délais de détection ou de présentation initiale qui mènent à
des phases plus avancées lors du diagnostic, et les difficultés de communication ou d’accès aux
soins de santé.
